Piper Sandler raised its price target on Ardelyx Inc (NASDAQ: ARDX) to $8 from $3 and upgraded to Overweight from a Neutral rating. The upgrade follows a surprisingly positive advisory committee vote ...
Tag: Kidney
Ardelyx stock rockets on heavy volume after positive FDA panel vote on kidney disease treatment
Shares of Ardelyx Inc. ARDX, +35.66% rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that be...
New York State Boldly Moves To Reduce Deaths From Kidney Disease
While the nation is convulsed by another gun shooting and activists demand new gun laws to address the epidemic, it’s worth noting that more people will die this year of an affliction that is mu...